Anixa Biosciences, Inc.

ANIX

$3.12

Name : Anixa Biosciences, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $102,700,776.00

EPSttm : -0.34

Anixa Biosciences, Inc.

$3.12

0.00%

$0.00000000000000

Float Short %

2.56

Margin Of Safety %

Put/Call OI Ratio

0.04

EPS Next Q Diff

-0.03

EPS Last/This Y

0.04

EPS This/Next Y

-0.03

Price

3.12

Target Price

Analyst Recom

Performance Q

-5.45

Relative Volume

0.43

Beta

0.48

Ticker: ANIX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-01	ANIX	4.4	0.04	0.00	7228
2025-12-02	ANIX	4.2	0.04	0.00	7276
2025-12-03	ANIX	4.84	0.04	0.00	7327
2025-12-04	ANIX	4.73	0.03	0.22	8158
2025-12-05	ANIX	4.77	0.05	0.07	8549
2025-12-08	ANIX	5.2	0.04	0.02	8932
2025-12-09	ANIX	5.05	0.04	0.01	9060
2025-12-10	ANIX	5.14	0.04	0.04	11030
2025-12-11	ANIX	4.8	0.04	0.27	11543
2025-12-12	ANIX	3.57	0.04	0.21	11862
2025-12-15	ANIX	3.26	0.04	0.10	11854
2025-12-16	ANIX	3.55	0.04	0.01	11717
2025-12-17	ANIX	3.27	0.04	0.34	11865
2025-12-18	ANIX	3.24	0.05	0.12	12027
2025-12-19	ANIX	3.3	0.05	0.14	12045
2025-12-22	ANIX	3.38	0.04	0.10	8350
2025-12-23	ANIX	3.3	0.04	0.00	8358
2025-12-26	ANIX	3.2	0.04	0.11	8370
2025-12-29	ANIX	3.19	0.04	0.00	8388
2025-12-30	ANIX	3.12	0.04	0.00	8375
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-01	ANIX	4.42	0.0	-	-0.35
2025-12-02	ANIX	4.20	0.0	-	-0.35
2025-12-03	ANIX	4.85	0.0	-	-0.35
2025-12-04	ANIX	4.74	0.0	-	-0.35
2025-12-05	ANIX	4.79	0.0	-	-0.35
2025-12-08	ANIX	5.22	0.0	-	-0.35
2025-12-09	ANIX	5.06	0.0	-	-0.35
2025-12-10	ANIX	5.15	0.0	-	-0.35
2025-12-11	ANIX	4.80	0.0	-	-0.35
2025-12-12	ANIX	3.58	0.0	-	-0.35
2025-12-15	ANIX	3.26	0.0	-	-0.35
2025-12-16	ANIX	3.26	0.0	-	-0.35
2025-12-17	ANIX	3.27	0.0	-	-0.35
2025-12-18	ANIX	3.22	0.0	-	-0.35
2025-12-19	ANIX	3.28	0.0	-	-0.35
2025-12-22	ANIX	3.38	0.0	-	-0.35
2025-12-23	ANIX	3.28	0.0	-	-0.35
2025-12-26	ANIX	3.20	0.0	-	-0.35
2025-12-29	ANIX	3.18	0.0	-	-0.35
2025-12-30	ANIX	3.12	0.0	-	-0.35
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-01	ANIX	2.60	0.37	2.07
2025-12-02	ANIX	2.60	0.37	2.07
2025-12-03	ANIX	2.60	0.37	2.07
2025-12-04	ANIX	2.60	0.37	2.07
2025-12-05	ANIX	2.60	0.37	2.07
2025-12-08	ANIX	2.01	0.37	2.07
2025-12-09	ANIX	2.01	0.37	2.07
2025-12-10	ANIX	2.01	0.37	1.82
2025-12-11	ANIX	2.01	0.37	1.82
2025-12-12	ANIX	2.01	0.37	1.82
2025-12-15	ANIX	2.01	0.37	1.82
2025-12-16	ANIX	2.01	0.37	1.82
2025-12-17	ANIX	2.01	0.37	1.82
2025-12-18	ANIX	2.01	0.37	1.82
2025-12-19	ANIX	2.01	0.37	1.82
2025-12-22	ANIX	2.01	0.37	1.82
2025-12-23	ANIX	1.99	0.37	1.82
2025-12-26	ANIX	1.99	0.37	2.56
2025-12-29	ANIX	1.99	0.37	2.56
2025-12-30	ANIX	1.99	0.37	2.56
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.07

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

1.99

Institutional Transactions

0.37

Beta

0.48

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

61.4

Max Drawdown 5-Year %

-70.2

Target Price

P/E

Forward P/E

PEG

P/S

P/B

6.17

P/Free Cash Flow

EPS

-0.34

Average EPS Est. Cur. Y

-0.35

EPS Next Y. (Est.)

-0.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.43

Return on Equity vs Sector %

-94.3

Return on Equity vs Industry %

-78.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

Anixa Biosciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 5

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company's vaccine programs include the development of a vaccine against breast cancer, initially focused on triple negative breast cancer (TNBC), the most lethal form of breast cancer; and the development of a vaccine against ovarian cancer, as well as a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

stock quote shares ANIX – Anixa Biosciences Inc Stock Price stock today

news today ANIX – Anixa Biosciences Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANIX – Anixa Biosciences Inc yahoo finance google finance

stock history ANIX – Anixa Biosciences Inc invest stock market

stock prices ANIX premarket after hours

ticker ANIX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ANIX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y